Glucose-regulated glucose uptake by transplanted muscle cells expressing glucokinase counteracts diabetic hyperglycemia

Human Gene Therapy

Volumn 13, Issue 18, 2002, Pages 2125-2133

  Otaegui, Pedro J ^a   Ontiveros, Maria ^a   Ferre, Tura ^a   Riu, Efren ^a   Jiménez, Rocio ^a   Bosch, Fatima ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BULIMIA; CELL TRANSPLANTATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; POLYDIPSIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 0036975805     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402320987824     Document Type: Article

References (46)

1. BAQUIÉ, S., MONTELL, E., GUINOVART, J.J., NEWGARD, C.B., and GÓMEZ-FOIX, A.M. (1998). Expression of glucokinase in cultured human muscle cells confers insulin-independent and glucose concentration-dependent increases in glucose disposal and storage. Diabetes 47, 1392-1398.
2. BARR, E., and LEIDEN, J.M. (1991). Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254, 1507-1509.
3. BLAU, H.M., CHIU, C.P., and WEBSTER, C. (1983). Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32, 1171-1180.
4. CHEN, C., PORE, N., BEHROOZ, A., ISMAIL-BEIGI, F., and MAITY, A. (2001). Regulation of glut1 mRNA by hypoxia-inducible factor-1: Interaction between H-ras and hypoxia. J. Biol. Chem. 276, 9519-9525.
5. CHIRGWIN, J.M., PRZYBYLA, A.E., MACDONALD, R.J., and RUTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
6. CLARK, S.A., QUAADE, C., CONSTANDY, H., HANSEN, P., HALBAN, P., FERBER, S., NEWGARD, C.B., and NORMINGTON, K. (1997). Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes 46, 958-967.
7. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. U.S.A. 89, 10892-10895.
8. DEGLON, N., HEYD, B., TAN, S.A., JOSEPH, J.M., ZURN, A.D., and AEBISHER, P. (1996). Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts. Hum. Gene Ther. 7, 2135-2146.
9. DHAWAN, J., PAN, L.C., PAVLATH, G.K., TRAVIS, M.A., LANCTOT, A.M., and BLAU, H.M. (1991). Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509-1512.
10. EFRAT, S. (1998). Prospects for gene therapy of insulin-dependent diabetes mellitus. Diabetologia 41, 1401-1409.
11. EXPERT COMMITTEE ON THE DIAGNOSIS AND CLASSIFICATION OF DIABETES MELLITUS. (1997). Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197.
12. FALQUI, L., MARTINENGHI, S., SEVERINI, G.M., CORBELLA, P., TAGLIETTI, M.V., ARCELLONI, C., SARUGERI, E., MONYI, L.D., PARONI, R., ODZIO, N., POZZA, G., and BORDIGNON, C. (1999). Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Hum. Gene Ther. 10, 1753-1762.
13. FERBER, S., BELTRANDELRIO, H., JOHNSON, J.H., NOEL, R.J., CASSIDY, L.E., CLARK, S., BECKER, T.C., HUGHES, S.D., and NEWGARD, C.B. (1994). GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release: Relationship to glucokinase activity. J. Biol. Chem. 269, 11523-11529.
14. FERRE, T., PUJOL, A., RIU, E., BOSCH, F., and VALERA, A. (1996a). Correction of diabetic alterations by glucokinase. Proc. Natl. Acad. Sci. U.S.A. 93, 7225-7230.
15. FERRE, T., RIU, E., BOSCH, F., and VALERA, A. (1996b). Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J. 10, 1213-1218.
16. GIBBS, E.M., STOCK, J.L., MCCOID, S.C., STUKENBROK, H.A., PESSIN, J.E., STEVENSON, R.W., MILICI, A.J., and MCNEISH, J.D. (1995). Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J. Clin. Invest. 95, 1512-1518.
17. GROS, L., MONTOLIU, L., RIU, E., LEBRIGAND, L., and BOSCH, F. (1997). Regulated production of insulin by non-β-cells. Hum. Gene Ther. 8, 2249-2259.
18. GROS, L., RIU, E., MONTOLIU, L., ONTIVEROS, M., LEBRIGAND, L., and BOSCH, F. (1999). Insulin production by engineered muscle cells. Hum. Gene Ther. 10, 1207-1217.
19. HOHMEIER, H.E., BELTRANDELRIO, H., CLARK, S.A., HENKELRIEGER, R., NORMINGTON, K., and NEWGARD, C.B. (1997). Regulation of insulin secretion from novel engineered insulinoma cell lines. Diabetes 46, 968-977.
20. HOLM, E., HAGMULLER, E., STAEDT, U., SCHLICKEISER, G., GUNTHER, H.J., LEWELING, H., TOKUS, M., and KOLLMAR, H.B. (1995). Substrate balances across colonic carcinomas in humans. Cancer Res. 55, 1373-1378.
21. IYNEDJIAN, P.B. (1993). Mammalian glucokinase and its gene. Biochem. J. 293, 1-13.
22. JIMÉNEZ-CHILLARÓN, J.C., NEWGARD, C.B., and GÓMEZFOIX, A.M. (1999). Increased glucose disposal induced by adeno-virus mediated transfer of glucokinase to skeletal muscle in vivo. FASEB J. 13, 2153-2160.
23. KUWAJIMA, M., NEWGARD, C.B., FOSTER, D.W., and MCGARRY, J.D. (1986). The glucose-phosphorylating capacity of liver as measured by three independent assays: Implications for the mechanism of hepatic glycogen synthesis. J. Biol. Chem. 261, 8849-8853.
24. LOMBARDI, A.M., MOLLER, D., LOIZEAU, M., GIRARD, J., and LETURQUE, A. (1997). Phenotype of transgenic mice overexpressing GLUT4 and hexokinase II in muscle. FASEB J. 611, 1137-1144.
25. LUMELSKY, N., BLONDEL, O., LAENG, P., VELASCO, I., RAVIN, R., and MCKAY, R. (2001). Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389-1394.
26. MUZZIN, P., EISENSMITH, R.C., COPELAND, K.C., and WOO, S.L.C. (1997). Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol. Endocrinol. 11, 833-837.
27. NEWGARD, C.B., HIRSCH, L.J., FOSTER, D.W., and MCGARRY, J.D. (1983). Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat: A direct or and indirect pathway? J. Biol. Chem. 258, 8046-8052.
28. NEWGARD, C.B., MOORE, S.V., FOSTER, D.W., and MCGARRY, J.D. (1984a). Efficient hepatic glycogen synthesis in refeeding rats requires continued carbon flow through the gluconeogenic pathway. J. Biol. Chem. 259, 6958-6953.
29. NEWGARD, C.B., FOSTER, D.W., and MCGARRY, J.D. (1984b). Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding. Diabetes 33, 192-195.
30. OTAEGUI, P.J., FERRE, T., PUJOL, A., RIU, E., JIMENEZ, R., and BOSCH, F. (2000). Expression of glucokinase in skeletal muscle: A new approach to counteract diabetic hyperglycemia. Hum. Gene Ther. 11, 1543-1552.
31. PICKUP, J.C., and WILLIAMS, G. (1994). In Chronic Complications of Diabetes. Blackwell Scientific Publications, Oxford.
32. PRINTZ, R.L., MAGNUSON, M.A., and GRANNER, D.K. (1993). Mammalian glucokinase. Annu. Rev. Nutr. 13, 463-496.
33. RAMIYA, V.K., MARAIST, M., ARFORS, K.E., SCHATZ, D.A., PACK, A.B., and CORNELIUS, J.G. (2000). Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat. Med. 6, 278-282.
34. REMUZZI, G., RUGGENENTI, P., and MAUER, S.M. (1994). Pancreas and kidney/pancreas transplants: experimental medicine or real inprovement? Lancet 343, 27-31.
35. REN, J.M., MARSHALL, B.A., GULVE, E.A., GAO, J., JOHNSON, D.W., HOLLOSZY, J.O., and MUECKLER, M. (1993). Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J. Biol. Chem. 268, 16113-16115.
36. RINSCH, C., REGULIER, E., DEGLON, N., DALLE, B., BEUZARD, Y., and AEBISCHER, P. (1997). A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum. Gene Ther. 8, 1881-1889.
37. RIU, E., BOSCH, F., and VALERA, A. (1996). Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver. Proc. Natl. Acad. Sci. U.S.A. 93, 2198-2202.
38. ROSSINI, A.A., APEL, M.C., WILLIAMS, R.M., and LIKE, A.A. (1977). Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. J. Am. Diabet. Assoc. 26, 916-920.
39. SHORT, D.K., OKADA, S., YAMAUCHI, K., and PESIN, J.E. (1998). Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. Am. J. Physiol. 275, E748-E756.
40. SIMPSON, A.M., MARSHALL, G.M., TUCH, B.E., MAXWELL, L., SZYMANSKA, B., TU, J., SEYNON, S., SWAN, M.A., and CAMACHO, M. (1997). Gene therapy of diabetes: Glucose-stimulated insulin secretion in a human hepatoma cell line (HEP G2ins/g). Gene Ther. 4, 1202-1215.
41. SORIA, B., ROCHE, E., BERNA, G., LEON-QUINTO, T., REIG, J.A., and MARTIN, F. (2000). Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49, 157-162.
42. TIEDGE, M., ELSNER, M., MCCLENAGAN, N.H., HEDRICH, H.J., GRUBE, D., KLEMPNAUER, J., and LENZEN, S. (2000). Engineering of a glucose-responsive surrogate cell for insulin replacement therapy of experimental insulin-dependent diabetes. Hum. Gene Ther. 11, 403-414.
43. TOZZO, E., GNUDI, L., and KAHN, B.B. (1997). Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology 138, 1604-1611.
44. VALERA, A., and BOSCH, F. (1994). Glucokinase expression in rat hepatoma cells induces glucose uptake and is rate limiting in glucose utilization. Eur. J. Biochem. 222, 533-539.
45. VANDROMME, M., GAUTHIER-ROUVIERE, C., CARNAC, G., LAMB, N., and FERNANDEZ, A. (1992). Serum response factor p67SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J. Cell Biol. 118, 1489-1500.
46. YAFFE, D., and SAXEL, O. (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727.